top
Search terms
Results 1 - 5 of 5 - ordered by :
Revistaespanola

Many reported risk factors for stroke in atrial fibrillation (AF) were derived from the non-warfarin arms of trial cohorts but in the historical trials, females were under-represented, many risk ...

Revista Española de Cardiología

Date : 01/04/2012 Item size : 35557 bytes
Revistaespanola

The authors concluded that dabigatran is efficient because the increase in costs does not exceed 30 000 euros/quality-adjusted life year gained, an acceptability threshold proposed in 2002.1 ...

Revista Española de Cardiología

Date : 01/06/2013 Item size : 37098 bytes
Revistaespanola

To the Editor, We would like to respond to the considerations of the author of the letter concerning our article.1 With respect to the doubts about the results obtained in our study and the ...

Revista Española de Cardiología

Date : 01/06/2013 Item size : 31557 bytes
Revistaespanola

[...]in our study, the key factor indicating the advantage of dabigatran over warfarin in terms of the cost-effectiveness ratio was not the cost of monitoring the international normalized ratio, but ...

Revista Española de Cardiología

Date : 01/06/2013 Item size : 33733 bytes
Revistaespanola

In cardiology anticoagulants are largely used to reduce thromboembolic complications in patients with acute coronary syndromes (ACS) or undergoing percutaneous coronary intervention (PCI), and in ...

Revista Española de Cardiología

Date : 01/11/2010 Item size : 63602 bytes